Atherogenesis: Current Understanding of the Causes of Atheroma

Indian Heart Journal

Volumn 52, Issue 4, 2000, Pages 467-472

  Weissberg, Peter L ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOSCLEROSIS; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; HOSPITALIZATION; HUMAN; INTIMA; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; RISK ASSESSMENT; VASCULAR SMOOTH MUSCLE;

ARTERIOSCLEROSIS; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; MALE; MUSCLE, SMOOTH, VASCULAR; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TUNICA INTIMA;

EID: 0034220295     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Sorensen KE, Celermajer DS, Georgakopoulos D, et al. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. J Clin Invest 1994; 93: 50-55
2. Ross R, Glomset J. The pathogenesis of atherosclerosis. Part: 1. N Engl J Med 1976; 295: 369-377
3. Shanahan C, Weissberg P. Smooth muscle cell heterogeneity - Patterns of gene expression in vascular smooth muscle cells in vitro and in vivo. Arterioscler Thromb Vasc Biol 1998; 18: 333-338
4. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995; 91: 2844-2850
5. Glagov S, Weisenberg E, Zarius C, et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987; 316: 371-375
6. Davies MJ. Stability and instability - 2 faces of coronary atherosclerosis. The Paul-Dudley-White lecture 1995. Circulation 1996; 94: 2013-2020
7. Ross R, Wight TN, Strandness E, et al. Human atherosclerosis. I: Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol 1984; 114: 79-93
8. Bennett MR, Macdonald K, Chan SW, et al. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques. Circ Res 1998; 82: 704-712
9. Davies MJ. Acute coronary thrombosis - The role of plaque disruption and its initiation and prevention. Eur Heart J 1995; 16 (Suppl L): 3-7
10. McNamara CA, Sarembock IJ, Bachhuber BG, et al. Thrombin and vascular smooth muscle cell proliferation: Implications for atherosclerosis and restenosis. Semin Thromb Hemost 1996; 22: 139-144
11. Falk E, Shah P, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-671
12. Callister TQ, Raggi P, Cooil B, et al. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 1998; 339: 1972-1978
13. Toussaint JF, LaMuraglia GM, Southern JF, et al. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation 1996; 94: 932-938
14. Ridker P, Cushman M, Stampfer M, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-979
15. MAAS Investigators. Effect of simvastatin on coronary atheroma: The Multicentre Anti-Atheroma Study (MAAS). Lancet 1994; 334: 633-638
16. Shepherd J, Cobbe S, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301-1307
17. LIPID Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) study. N Engl J Med 1998; 339: 1349-1357
18. Scandinavian Simvastatin Survival Study (4S) Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet 1994; 344: 1383-1389
19. Williams JK, Sukhova GK, Herrington DM, et al. Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys. J Am Coll Cardiol 1998; 31: 684-691
20. Treasure CB, Klein JL, Weintraub WS, et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995; 332: 481-487
21. Rosenson RS, Tangney CC. Antiatherothrombotic properties of statins: Implications for cardiovascular event reduction. JAMA 1998; 279: 1643-1650